[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 445, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 63, "title": "Chairperson, CEO & President", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 1144497, "exercisedValue": 0, "unexercisedValue": 12278804}, {"maxAge": 1, "name": "Dr. Ian  Taylor Ph.D.", "age": 61, "title": "President of Research & Development and Chairman of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 732256, "exercisedValue": 0, "unexercisedValue": 1344633}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 54, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 49, "title": "VP, Chief Accounting Officer & Corporate Controller", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Boyle", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 54, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 53, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John A. Grosso Ph.D.", "age": 66, "title": "Senior Vice President of R&D Technical Operations", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 43, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 26.9, "open": 28.54, "dayLow": 27.245, "dayHigh": 28.83, "regularMarketPreviousClose": 26.9, "regularMarketOpen": 28.54, "regularMarketDayLow": 27.245, "regularMarketDayHigh": 28.83, "beta": 1.971, "forwardPE": -6.006438, "volume": 737755, "regularMarketVolume": 737755, "averageVolume": 571257, "averageVolume10days": 664050, "averageDailyVolume10Day": 664050, "bid": 27.8, "ask": 28.2, "bidSize": 700, "askSize": 700, "marketCap": 1923279744, "fiftyTwoWeekLow": 14.02, "fiftyTwoWeekHigh": 53.08, "priceToSalesTrailing12Months": 11.938422, "fiftyDayAverage": 25.6514, "twoHundredDayAverage": 32.4015, "currency": "USD", "enterpriseValue": 803179584, "profitMargins": -1.91558, "floatShares": 57184414, "sharesOutstanding": 68713104, "sharesShort": 9321685, "sharesShortPriorMonth": 12756198, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.1357, "heldPercentInsiders": 0.07215, "heldPercentInstitutions": 1.0701799, "shortRatio": 17.66, "shortPercentOfFloat": 0.1381, "impliedSharesOutstanding": 68969504, "bookValue": 8.53, "priceToBook": 3.28136, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -308600000, "trailingEps": -4.79, "forwardEps": -4.66, "pegRatio": 2.49, "enterpriseToRevenue": 4.986, "enterpriseToEbitda": -2.278, "52WeekChange": 0.7744063, "SandP52WeekChange": 0.3301804, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ARVN", "underlyingSymbol": "ARVN", "shortName": "Arvinas, Inc.", "longName": "Arvinas, Inc.", "firstTradeDateEpochUtc": 1538055000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "5ab3d208-4f36-3880-916e-a34548e61b36", "messageBoardId": "finmb_243040896", "gmtOffSetMilliseconds": -18000000, "currentPrice": 27.99, "targetHighPrice": 110.0, "targetLowPrice": 28.0, "targetMeanPrice": 63.61, "targetMedianPrice": 61.5, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 18, "totalCash": 1121600000, "totalCashPerShare": 16.323, "ebitda": -352600000, "totalDebt": 1500000, "quickRatio": 4.119, "currentRatio": 4.166, "totalRevenue": 161100000, "debtToEquity": 0.256, "revenuePerShare": 2.327, "returnOnAssets": -0.20069, "returnOnEquity": -0.59164, "freeCashflow": -170112496, "operatingCashflow": -258300000, "revenueGrowth": 1.96, "grossMargins": 1.0, "ebitdaMargins": -2.1887, "operatingMargins": -0.58887, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-07"}]